Summary Expression of c-myc was studied immunohistochemically in 100 colorectal carcinomas, using a monoclonal antibody, Myc 1-6E10, which is purported to recognize the oncoprotein (p62c-'Yc) in paraffinembedded material. In normal epithelium, maturing crypt cells and terminally differentiated surface cells were positive, and proliferating basal crypt cells negative. All carcinomas stained positively, but intensity was independent of histological differentiation, Dukes' stage, DNA ploidy and survival. Staining was predominantly cytoplasmic despite the suspected nuclear location of p62c-mYc and there was considerable staining of fibroblasts. When staining was compared in frozen and paraffin-embedded sections fixed in different ways, different patterns were observed. Acetone-fixed frozen sections exhibited weak nuclear and cytoplasmic staining or were negative. In formol-saline fixed frozen sections, there was stronger predominantly nuclear staining. In paraffin-embedded sections staining was predominantly cytoplasmic. This study suggests that c-myc expression is enhanced in the majority of colorectal carcinomas and although independent of clinical behaviour, may be a common event in malignant transformation. However, since staining is affected by fixation and processing, data obtained using Myc 1-6E10 on routinely processed specimens should be interpreted with caution.
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At least 40 viral and cellular oncogenes and proto-oncogenes have been identified Weinberg, 1985; Barbacid, 1986) . Proto-oncogenes are normal cellular genes which are present in all cells and involved in the regulation of proliferation and differentiation. They may become converted to oncogenes by point mutation, chromosomal rearrangement or amplification. However, the precise functions of these genes in normal and neoplastic cells are uncertain.
The c-myc oncogene encodes for a 62,000 molecular weight protein product, p62c-mYc (Alitalo et al., 1983; Hann & Eisenman, 1984) , which is predominantly located in the nucleus (Eisenman et al., 1985; Evan & Hancock, 1985) and thought to be involved in the regulation of cellular proliferation. A definitive role for the oncoprotein has not been elucidated; however, the cellular homologues of the c-myc gene are highly conserved across species suggesting that it is of considerable functional importance. There is a background level of c-myc expression which increases when quiescent cells are stimulated to proliferate and decreases with terminal differentiation. Expression of the c-myc gene is regulated at both transcriptional and post-transcriptional levels (reviewed in; Cole, 1986; Eisenman & Thompson, 1986; Alitalo et al., 1987) .
The c-myc locus is situated on the long arm of chromosome 8 and is commonly involved in the genetic alterations of malignancy. In Burkitt's lymphoma the segment of chromosome 8 carrying the c-myc locus is commonly translocated to chromosome 14 and less commonly to either chromosome 2 or 22. The c-myc locus is juxtaposed to an immunoglobulin locus which is extremely active in B lymphocytes due to chronic Epstein-Barr virus exposure. This may result in deregulation and inappropriate expression of the c-myc gene; a phenomenon of potential importance in the pathogenesis of B cell lymphoma (reviewed in; Klein & Klein, 1985; Cole, 1986) .
Elevated levels of c-myc mRNA and p62c-myc have been detected in cell lines and solid tumours using molecular biological techniques. Meltzer et al. (1987) The study of oncogene expression has been potentially facilitated by the recent development of monoclonal antibodies to oncoproteins. These reagents are easily applied to tissue sections and qualitative information obtained on the cellular distribution of the oncoprotein. Quantitative data are however, less readily acquired.
The sequence of nucleotides of the c-myc gene has been identified and p62c-myc deduced to be a 439 amino acid product. Hydrophilic portions of the protein theoretically lie on the external surface of the molecule and are therefore potentially antigenic. Synthetic peptide fragments have been constructed corresponding to these regions and used as immunogens to raise monoclonal antibodies which recognize the intact oncoprotein . An 18 amino acid peptide fragment corresponding to residues 171-188 was used to raise a mouse monoclonal antibody Myc 1-6E10. This antibody immunoprecipitates a 62-kD protein from cell lysates and specifically binds to a 62-kD protein in electroblotted cell extracts. A 62-kD protein of identical mobility is recognized by a polyclonal rabbit antibody which recognizes the human c-myc gene product . Myc 1-6E10 is also claimed to recognize p62c-mYc in routinely processed paraffin-embedded specimens .
In this study Myc 1-6E10 has been used to assess c-myc oncogene expression in colorectal cancer.
Materials and methods
The main study group consisted of 100 patients presenting with colorectal cancer between 1981 and 1983. All have been prospectively followed for three years. Normal mucosa was obtained from the most distant resection margin of 22 recent cases and from 10 patients with irradiation bowel disease.
Myc 1-6E10 was obtained from Prof. K. Sikora and following titration, used at a concentration of 1:500 in Tris buffered saline (TBS).
Paraffin-embedded tissue sections were stained using a three step immunoperoxidase technique. Sections (4 pum) were dewaxed in xylene, rehydrated through a series of ethanols, and endogenous peroxidase activity blocked using 0.5% hydrogen peroxide in methanol for 20 min. Sections were then incubated with the primary mouse monoclonal antibody for 60 min, and subsequently with peroxidase conjugated rabbit anti-mouse and peroxidase conjugated swine antirabbit sera, each for 30 min. Slides were washed in TBS between each incubation step. The peroxidase reaction was developed using diaminobenzidine in TBS (0.6mg ml-1) containing fresh hydrogen peroxide (0.01%), producing a brown stain in areas of antibody binding. (Figure 1 ).
All 100 carcinomas stained positively but with varying distribution and intensity; staining was uniform in 51 ( Figure  2 ) and patchy in 49 (Figure 3) .
Twenty-nine stained weakly, 42 moderately and 29 strongly. Similar staining patterns were observed for. different histological grades (Table I) and Dukes' stage (Table II) .
Thirty-six were DNA diploid and 64 DNA aneuploid. DNA ploidy status was independent of staining pattern (Table III) .
The prognosis was similar for each sub-group; 52% of patients with weak, 45% with moderate and 48% with strong staining survived three years.
In both normal and neoplastic tissue staining was predominantly cytoplasmic (Figures 1 and 2 ), although in 6 carcinomas moderate nuclear staining was observed ( Figure  4 ). There was also moderate staining of stromal elements and smooth muscle (Figures 1 and 2 ).
Effects offixation on staining Acetone fixed cryostat sections exhibited weak nuclear and cytoplasmic staining or were negative. Adjacent sections fixed in formol-saline exhibited stronger staining which was both nuclear and cytoplasmic. Corresponding routinely processed formol-saline fixed paraffin-embedded samples revealed predominantly cytoplasmic staining.
Acetone fixed SW620 cells exhibited predominantly nuclear staining ( Figure 5 ). In formol-saline fixed SW620 cells, staining was predominantly cytoplasmic, being strongest in mitotic cells ( Figure 5 ).
Discussion
The development of monoclonal antibodies which specifically recognize oncoproteins should theoretically facilitate the study of oncogene expression in human tumour samples.
The p62cmYc gene product has hitherto been considered to be predominantly nuclear in cellular location (Eisenman et al., 1985; Evan & Hancock, 1985) . C-myc expression increases when quiescent GO Ciclitira et al. (1987) reported different staining patterns with this antibody. Normal colonic epithelium was negative apart from some very weak staining of occasional superficial enterocytes. Positive staining was observed in inflammatory bowel disease especially in association with marked lymphocytic infiltration and dysplastic change. Cytoplasmic disperson of p62c-mYc with other nuclear components occurs during mitosis (Eisenman et al., 1985) and is demonstrated in this study by stronger staining in mitotic SW260 cells. However, cytoplasmic staining was also prominent in non-proliferating cells. The oncoprotein is extracted from the nucleus by mild salt concentrations and by fixation (Evan & Hancock, 1985; Stewart et al., 1986) . It is also suggested that redistribution of the protein to the cytoplasm could occur during maturation and differentiation (Hendy-Ibbs et al., 1987) . The results in the present study show that the observed staining patterns are largely a function of processing rather than a biological phenomenon. Since acetone fixed cryostat sections were only weakly positive or negative, formol-saline fixation presumably either 'unmasks' or modifies the protein recognized by Myc 1-6E10 so as to facilitate antibody binding. The differences between formol-saline fixed cryostat sections and formol-saline fixed paraffin-embedded sections may be due to differences in tissue penetration of the fixative. Extensive staining of differentiated cells including fibroblasts and smooth muscle, could be due to cross reaction with proteins other than p62c-mYc. Alternatively, the peptide fragment used to raise Myc 1-6E10 may be common to other proteins or the antibody may bind to similar sequences in unrelated proteins. Antibody binding could be blocked with the peptide immunogen; however, this would inhibit non-specific as well as specific staining.
Jack et al. (1986) studied c-myc expression in malignant lymphomas using Myc 1-6E10. The p62c-mYc product was predominantly cytoplasmic and widely distributed in normal tissue, but was detected in only a minority of lymphomas. A second antibody Myc 1-9E10, which recognizes a different site on p62c-mYc gave similar staining patterns. This was considered to militate against significant cross reactivity and non-specific binding. On completion of the present study, Myc 1-9E10 was acquired and found to give closely similar staining patterns in our colorectal carcinomas. Sikora et al. (1987) studied c-myc expression in 15 colorectal carcinomas using molecular biological and immunocytochemical techniques. There was close correlation between c-myc mRNA copy number and p62c-mYc abundance, detected by immunoblotting using Myc 1-6E10, mRNA levels were greater in tumour compared to normal mucosa. Immunohistology of corresponding sections showed staining of low intensity in normal maturing crypt cells. Carcinomas stained strongly if well differentiated, but weakly if poorly differentiated.
These studies are consistent with the protein recognized by In the present study DNA ploidy was determined by flow cytometry using adjacent paraffin-embedded sections (see also Jones et al., 1988) . Enhanced expression of p62c-mYc was a feature of both DNA diploid and DNA aneuploid tumours suggesting that increased c-myc expression is a feature of both minor and major chromosomal rearrangements. Flow cytometric techniques have been developed for the simultaneous measurement of p62c-mYc levels and DNA content in nuclei extracted from paraffin-embedded material with somewhat inconsistent results. In breast cancer, elevated levels of p62c-myc were associated with poor prognostic factors (Dowle et al., 1987) . Conversely in testicular cancer decreasing levels were associated with decreasing histological differentiation . Normal cervical epithelium was found to have higher levels than cervical carcinomas (Hendy-Ibbs et al., 1987) . However, when tissue sections were stained using Myc 1-6E10, normal cervical epithelium was negative and carcinomas were positive (Covington et al., 1987) . In our view the cytoplasmic staining observed with Myc 1-6E10 effectively precludes its use in a flow cytometric technique that utilizes nuclei alone and probably accounts for these inconsistent results.
Monoclonal antibodies have also been raised to ras gene products. To date these have also proved to be of limited value for the immunohistochemical detection of ras products. This is due to non-specific binding, an inability to distinguish normal from mutant ras products and normal from neoplastic tissues (Ghosh et al., 1986; Robinson et al., 1986; Carney et al., 1986) .
If monoclonal antibodies to oncoproteins are to be used on routinely processed specimens, there is clearly a need for new reagents of greater specificity. Ideally the results obtained with such antibodies should be evaluated with comparative information from hybridisation and protein extraction studies.
In conclusion, these data suggest that c-myc oncogene expression is a feature of normal maturing and terminally differentiated mucosal cells. Expression is increased to a quantitatively indefinable extent in the majority of colorectal carcinomas, but is unrelated to clinical behaviour. However, in view of the paradoxical staining patterns, data obtained using Myc 1-6E10 on routinely processed samples should be interpreted with caution.
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